Heron Therapeutics: 2Q Earnings Snapshot
Aug. 08, 2018
SAN DIEGO (AP) _ Heron Therapeutics Inc. (HRTX) on Wednesday reported a loss of $38.7 million in its second quarter.
The San Diego-based company said it had a loss of 54 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.
The pharmaceutical company posted revenue of $17.3 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $14 million.
Heron Therapeutics shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.